Fig. 11From: Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safetyThe efficacy/safety ratio. The relationship between the efficacy: adverse effect ratio and the cumulative doseBack to article page